DYNAGEN INC
10QSB, EX-27, 2000-11-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DYNAGEN INC, 10QSB, EX-10.6, 2000-11-14
Next: UNIVERSAL EXPRESS INC/, NT 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         382,340
<SECURITIES>                                         0
<RECEIVABLES>                                6,093,084
<ALLOWANCES>                                    25,918
<INVENTORY>                                  8,292,544
<CURRENT-ASSETS>                            15,778,852
<PP&E>                                       5,560,321
<DEPRECIATION>                               1,735,737
<TOTAL-ASSETS>                              22,316,036
<CURRENT-LIABILITIES>                       15,548,856
<BONDS>                                      4,963,521
                                0
                                        578
<COMMON>                                       862,612
<OTHER-SE>                                     940,469
<TOTAL-LIABILITY-AND-EQUITY>                22,316,036
<SALES>                                     24,691,916
<TOTAL-REVENUES>                            24,691,916
<CGS>                                       19,426,654
<TOTAL-COSTS>                                8,363,279
<OTHER-EXPENSES>                              (802,714)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,549,253
<INCOME-PRETAX>                             (3,844,556)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (3,844,556)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (3,844,556)
<EPS-BASIC>                                      (0.07)
<EPS-DILUTED>                                    (0.07)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission